$6B
Annual blockbuster drug revenue
Lean Lab Transformation Boosts R&D Capacity by 29% in Pharma
A leading pharmaceutical company partnered with EFESO to increase workload capacity at its R&D facility while maintaining schedule adherence for ongoing projects. Through Lean Lab methodologies and optimized planning, the client achieved significant gains in lab utilization and operational efficiency without additional resources.
Life Sciences
Lean Lab
People and Organization
Our Client
The client is a leading pharmaceutical company whose R&D facility is responsible for developing the next generation of biologically derived drugs, including a $6 billion-per-year blockbuster. The site’s advanced bioreactor lab required optimization to unlock additional capacity and support accelerated innovation.
The Challenge
The client needed to increase project workload capacity at their Research & Development (R&D) facility while maintaining schedule adherence for current project workloads.
The project aimed to optimize and increase the utilization of advanced bioreactor laboratories at a site responsible for developing the next generation analogues of a portfolio of biologically derived (large molecule) drugs.
Real Results Achieved Together
Through the implementation of lean laboratory methodologies and optimized planning processes, the pharmaceutical R&D facility achieved significant improvements in capacity utilization and operational efficiency.
+29%
Increase in advanced bioreactor lab utilization
Transformation Impact
- A robust capacity planning process maximized equipment utilization, freeing scientists to focus on innovation while minimizing time spent on non-value-added activities.
- A standard rhythm wheel leveling strategy, visual management systems, and structured workflows further strengthened consistency and performance.
- Significant reduction in downtime due to enhanced planning and re-engineered changeover processes
- Marked increase in overall project workload capacity without additional equipment or scientist resourcing
Our Approach
EFESO supported the transformation by:
- Optimizing the utilization of the advanced bioreactor lab while improving the schedule adherence of current project workloads.
- Strengthening the robustness of the capacity planning process for all projects to maximize equipment utilization and allow scientists to focus on scientific innovation.
- Implementing a rhythm wheel leveling strategy for the preculture processes.
- Establishing standard work practices for sampling and the analysis of results.
- Introducing an electronic visual management system to plan, monitor project progress, and report instructive KPIs.
Related Services
Volatile workloads create productivity troughs and lead-time peaks. We stabilize lab operations through capacity modeling, dynamic resource allocation, and lean process optimization.
Together, we’ll develop performance-driven behaviors that turn intention into action—mobilizing teams, accelerating adoption, and sustaining results.
Ready to Unlock Hidden Capacity in Your R&D Operations?
- Transform your lab into a high-performing innovation engine that delivers more breakthroughs with existing resources
- Stop losing valuable research time to inefficient planning and equipment bottlenecks
- Join pharmaceutical leaders who’ve achieved double-digit capacity gains without adding headcount
Discover More Clients Results
15%
Improvement in delivery performance (OTIF)
Resources Mining and Processing
EFESO supported KME Group in integrating Sales & Operations Planning (S&OP) with its broader supply chain, driving strategic alignment, improving delivery performance by 15%, and reducing metal stock by 33%, resulting in a €100 million financial impact.
€90M
in Opportunities identified during the program
Chemicals
A global chemical company launched a joint performance improvement initiative with EFESO across twelve plants on four continents. Significant improvements in cost drivers and margins were achieved.
-17%
Lead time reduction
Industrial Manufacturing
Packaging machinery group needed lead time and inventory optimization. We conducted comprehensive value stream analysis, identified bottlenecks, and developed transformation roadmap, targeting 40% reduction potential.
8-10%
Transformation cost reduction achieved
Aerospace & Defense
Aerospace corporation faced fragmented digital infrastructure across divisions. We launched enterprise-wide transformation, integrated systems, and drove operational excellence, reducing operational costs by 10%.
$25M
Cost reduction through organizational optimization
Chemicals
Specialty chemicals leader faced cost and reliability operational challenges. We harmonized processes, implemented enterprise standard work, and optimized operations, delivering $25M in annual savings.
€30M
Recurring annual savings
Automotive and Commercial Vehicles
Automotive supplier with 21 sites faced declining EBITDA margins. We designed holistic lean transformation, deployed continuous improvement, and aligned global operations, delivering €30M in sustained savings.
$10M
Fixed cost reduction (first year)
Chemicals
Private Equity
Petrochemical manufacturer needed operational excellence across multiple plants. We standardized best practices, implemented digital solutions, and optimized energy usage, reducing operating costs by 15%.
5K x
Revenue growth in less than a decade
Automotive and Commercial Vehicles
Battery manufacturer needed rapid global scaling while maintaining quality. We implemented lean production, digital integration, and workforce development, supporting expansion to €60B market valuation.